Occupational & Environmental lung Disease
Occupational & Environmental lung diseases are group of diseases caused by the inhalation of dust, chemicals, or proteins. The severity of the disease is identified with the material inhaled and the intensity of exposure. Some of the Occupational Lung diseases are Asthma, Bronchiolitis Obliterans, COPD, Hypersensitivity Pneumonitis, Lung Cancer, Mesothelioma, Pneumoconiosis. Some of the Environmental lung diseases caused by Arsenic, Asbestos, BCME, Beryllium, Cadmium, Chromium, Coal dust, Diesel exhaust, Indium lung, Nickel, Silica and Tobacco smoke etc.
Related Conference of Occupational & Environmental lung Disease
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Occupational & Environmental lung Disease Conference Speakers
Recommended Sessions
- Asthma and allergy
- Cardiovascular Risk and COPD
- CO-Morbidities in COPD
- COPD Exacerbations
- COPD Management
- Epidemiology of COPD
- Interstitial Lung Disease
- Lung cancer
- Lung Diseases
- Lung Transplantation
- Occupational & Environmental lung Disease
- Pathogenesis of COPD
- Prevention of COPD
- Pulmonary Hypertension
- Pulmonary, Critical care and Sleep
- Respiratory Infections
- Therapeutic Devices and Evaluation
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Allergy testing and treatment in respiratory diseases - Euro Pulmonology 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Bronchial thermoplasty for asthma management - Euro Pulmonology 2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic cough evaluation and treatment strategies - Euro Pulmonology 2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and its impact on respiratory health - Euro Pulmonology 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Genetics of respiratory diseases and precision medicine - Euro Pulmonology 2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Imaging techniques in pulmonary medicine - Euro Pulmonology 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Interstitial lung disease and lung transplant outcomes - Euro Pulmonology 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung cancer and personalized medicine approaches - Euro Pulmonology 2024 (France)
- Lung cancer screening and early detection programs - Euro Pulmonology 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung microbiome and respiratory diseases - Euro Pulmonology 2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Non-invasive ventilation techniques and outcomes - Euro Pulmonology 2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational asthma and work-related respiratory diseases - Euro Pulmonology 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary arterial hypertension diagnosis and management - Euro Pulmonology 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary drug delivery systems and innovations - Euro Pulmonology 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary edema pathophysiology and treatment - Euro Pulmonology 2024 (France)
- Pulmonary embolism diagnosis and management - Euro Pulmonology 2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- Pulmonary rehabilitation in critically ill patients - Euro Pulmonology 2024 (France)
- Pulmonary sarcoidosis diagnosis and treatmen - Euro Pulmonology 2024 (France)
- Respiratory failure management in ICU patients - Euro Pulmonology 2024 (France)
- Respiratory syncytial virus updates and management - Euro Pulmonology 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)